GEVO
Gevo, Inc.
Key Financials
Gross Profit
$-11454000
↓ 21.0%
Operating Income
$-20212000
↑ 77.7%
Revenue
$160.6M
↑ 849.3%
Net Income
$-33836000
↑ 57.0%
EPS (Diluted)
$-0.14
↑ 58.8%
Total Liabilities
$247.8M
↑ 162.3%
Shareholders' Equity
$466.3M
↓ 4.7%
Cash & Equivalents
$81.2M
↓ 57.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/13/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| SCHEDULE 13G | 8/7/2026 | View on SEC |
| 10-Q | 8/6/2026 | View on SEC |
| 144 | 8/6/2026 | View on SEC |
| 144 | 8/6/2026 | View on SEC |
| 144 | 8/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GEVO |
| Company Name | Gevo, Inc. |
| CIK | 1392380 |
| Sector | Industrial Organic Chemicals |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2860 |
| SIC Description | Industrial Organic Chemicals |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 303-858-8358 |